PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings
Buy
Hold
Sell

We haven’t received any recent analyst ratings for PHAS.

We couldn't find any ratings matching your filter criteria.